NCT01207596View on ClinicalTrials.gov

Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Neuropathic Pain
Interventions
DRUG

Hydromorphone

Oral hydromorphone extended release, once daily

Trial Locations (1)

66211

International Clinical Research Institute, Leawood

Sponsors
All Listed Sponsors
lead

International Clinical Research Institute

OTHER